 |
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Viral protein/DNA
|
PDB id
|
|
|
|
1hvn
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Biochemical function
|
nucleic acid binding
|
2 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
Protein Sci
2:3
(1993)
|
|
PubMed id:
|
|
|
|
|
| |
|
Zinc- and sequence-dependent binding to nucleic acids by the N-terminal zinc finger of the HIV-1 nucleocapsid protein: NMR structure of the complex with the Psi-site analog, dACGCC.
|
|
T.L.South,
M.F.Summers.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The nucleic acid interactive properties of a synthetic peptide with sequence of
the N-terminal CCHC zinc finger (CCHC = Cys-X2-Cys-X4-His-X4-Cys; X = variable
amino acid) of the human immunodeficiency virus (HIV) nucleocapsid protein,
Zn(HIV1-F1), have been studied by 1H NMR spectroscopy. Titration of Zn(HIV1-F1)
with oligodeoxyribonucleic acids containing different nucleotide sequences
reveals, for the first time, sequence-dependent binding that requires the
presence of at least one guanosine residue for tight complex formation. The
dynamics of complex formation are sensitive to the nature of the residues
adjacent to guanosine, with residues on the 3' side of guanosine having the
largest influence. An oligodeoxyribonucleotide with sequence corresponding to a
portion of the HIV-1 psi-packaging signal, d(ACGCC), forms a relatively tight
complex with Zn(HIV1-F1) (Kd = 5 x 10(-6) M). Two-dimensional nuclear Overhauser
effect (NOESY) data indicate that the bound nucleic acid exists predominantly in
a single-stranded, A-helical conformation, and the presence of more than a dozen
intermolecular NOE cross peaks enabled three-dimensional modeling of the
complex. The nucleic acid binds within a hydrophobic cleft on the peptide
surface. This hydrophobic cleft is defined by the side chains of residues Val1,
Phe4, Ile12, and Ala13. Backbone amide protons of Phe4 and Ala13 and the
backbone carbonyl oxygen of Lys2 that lie within this cleft appear to form
hydrogen bonds with the guanosine O6 and N1H atoms, respectively. In addition,
the positively charged side chain of Arg14 is ideally positioned for
electrostatic interactions with the phosphodiester backbone of the nucleic acid.
The structural findings provide a rationalization for the general conservation
of these hydrophobic and basic residues in CCHC zinc fingers, and are consistent
with site-directed mutagenesis results that implicate these residues as direct
participants in viral genome recognition.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 10.
Fig. 10. Stereorawin of arepre-
sentative Zn(HIV1-Fl):d(ACGCC)
structure (peptide backbone in blue
and nucleic acid in redshowing the
topology of more prominent in-
ermolecular NOEs observed Cgreen).
|
 |
Figure 12.
Wig. 12. Space-fiing representation ofZn(HIV1-F1)shoing the hy-
drophobic left byconservatively substitutedVal', Phe4,
and Alag3 residues (the nucleicacidhs been removed clarity).
ithinthiscleft, the backboneamidesof Phe4 and la,and the car-
onyloxygen of are poised to form hydrogen bonds to h 3.
Sidechains are coloredaccording to theShapelymodelcoloringscheme
(blue,basic;green,hydrophobic; red, acidic). figure as generated
withRASTE3D software.
|
 |
|
|
|
| |
The above figures are
reprinted
from an Open Access publication published by the Protein Society:
Protein Sci
(1993,
2,
3-0)
copyright 1993.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
D.Sela,
and
J.Shlomai
(2009).
Regulation of UMSBP activities through redox-sensitive protein domains.
|
| |
Nucleic Acids Res, 37,
279-288.
|
 |
|
|
|
|
 |
T.T.Baig,
J.M.Lanchy,
and
J.S.Lodmell
(2009).
Randomization and in vivo selection reveal a GGRG motif essential for packaging human immunodeficiency virus type 2 RNA.
|
| |
J Virol, 83,
802-810.
|
 |
|
|
|
|
 |
K.M.Stewart-Maynard,
M.Cruceanu,
F.Wang,
M.N.Vo,
R.J.Gorelick,
M.C.Williams,
I.Rouzina,
and
K.Musier-Forsyth
(2008).
Retroviral nucleocapsid proteins display nonequivalent levels of nucleic acid chaperone activity.
|
| |
J Virol, 82,
10129-10142.
|
 |
|
|
|
|
 |
E.Burkala,
and
M.Poss
(2007).
Evolution of feline immunodeficiency virus Gag proteins.
|
| |
Virus Genes, 35,
251-264.
|
 |
|
|
|
|
 |
J.Zhou,
R.L.Bean,
V.M.Vogt,
and
M.Summers
(2007).
Solution structure of the Rous sarcoma virus nucleocapsid protein: muPsi RNA packaging signal complex.
|
| |
J Mol Biol, 365,
453-467.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
T.Wu,
S.L.Heilman-Miller,
and
J.G.Levin
(2007).
Effects of nucleic acid local structure and magnesium ions on minus-strand transfer mediated by the nucleic acid chaperone activity of HIV-1 nucleocapsid protein.
|
| |
Nucleic Acids Res, 35,
3974-3987.
|
 |
|
|
|
|
 |
V.D'Souza,
and
M.F.Summers
(2005).
How retroviruses select their genomes.
|
| |
Nat Rev Microbiol, 3,
643-655.
|
 |
|
|
|
|
 |
I.Onn,
N.Milman-Shtepel,
and
J.Shlomai
(2004).
Redox potential regulates binding of universal minicircle sequence binding protein at the kinetoplast DNA replication origin.
|
| |
Eukaryot Cell, 3,
277-287.
|
 |
|
|
|
|
 |
R.S.Russell,
C.Liang,
and
M.A.Wainberg
(2004).
Is HIV-1 RNA dimerization a prerequisite for packaging? Yes, no, probably?
|
| |
Retrovirology, 1,
23.
|
 |
|
|
|
|
 |
J.Guo,
T.Wu,
J.Anderson,
B.F.Kane,
D.G.Johnson,
R.J.Gorelick,
L.E.Henderson,
and
J.G.Levin
(2000).
Zinc finger structures in the human immunodeficiency virus type 1 nucleocapsid protein facilitate efficient minus- and plus-strand transfer.
|
| |
J Virol, 74,
8980-8988.
|
 |
|
|
|
|
 |
P.E.Johnson,
R.B.Turner,
Z.R.Wu,
L.Hairston,
J.Guo,
J.G.Levin,
and
M.F.Summers
(2000).
A mechanism for plus-strand transfer enhancement by the HIV-1 nucleocapsid protein during reverse transcription.
|
| |
Biochemistry, 39,
9084-9091.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
C.Vuilleumier,
E.Bombarda,
N.Morellet,
D.Gérard,
B.P.Roques,
and
Y.Mély
(1999).
Nucleic acid sequence discrimination by the HIV-1 nucleocapsid protein NCp7: a fluorescence study.
|
| |
Biochemistry, 38,
16816-16825.
|
 |
|
|
|
|
 |
A.Y.Louie,
and
T.J.Meade
(1998).
A cobalt complex that selectively disrupts the structure and function of zinc fingers.
|
| |
Proc Natl Acad Sci U S A, 95,
6663-6668.
|
 |
|
|
|
|
 |
R.N.De Guzman,
R.B.Turner,
and
M.F.Summers
(1998).
Protein-RNA recognition.
|
| |
Biopolymers, 48,
181-195.
|
 |
|
|
|
|
 |
U.K.von Schwedler,
T.L.Stemmler,
V.Y.Klishko,
S.Li,
K.H.Albertine,
D.R.Davis,
and
W.I.Sundquist
(1998).
Proteolytic refolding of the HIV-1 capsid protein amino-terminus facilitates viral core assembly.
|
| |
EMBO J, 17,
1555-1568.
|
 |
|
|
|
|
 |
Y.Gao,
K.Kaluarachchi,
and
D.P.Giedroc
(1998).
Solution structure and backbone dynamics of Mason-Pfizer monkey virus (MPMV) nucleocapsid protein.
|
| |
Protein Sci, 7,
2265-2280.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
N.Sheng,
S.C.Pettit,
R.J.Tritch,
D.H.Ozturk,
M.M.Rayner,
R.Swanstrom,
and
S.Erickson-Viitanen
(1997).
Determinants of the human immunodeficiency virus type 1 p15NC-RNA interaction that affect enhanced cleavage by the viral protease.
|
| |
J Virol, 71,
5723-5732.
|
 |
|
|
|
|
 |
E.Schmalzbauer,
B.Strack,
J.Dannull,
S.Guehmann,
and
K.Moelling
(1996).
Mutations of basic amino acids of NCp7 of human immunodeficiency virus type 1 affect RNA binding in vitro.
|
| |
J Virol, 70,
771-777.
|
 |
|
|
|
|
 |
J.F.Kaye,
and
A.M.Lever
(1996).
trans-acting proteins involved in RNA encapsidation and viral assembly in human immunodeficiency virus type 1.
|
| |
J Virol, 70,
880-886.
|
 |
|
|
|
|
 |
K.de Vreese,
V.Kofler-Mongold,
C.Leutgeb,
V.Weber,
K.Vermeire,
S.Schacht,
J.Anné,
E.de Clercq,
R.Datema,
and
G.Werner
(1996).
The molecular target of bicyclams, potent inhibitors of human immunodeficiency virus replication.
|
| |
J Virol, 70,
689-696.
|
 |
|
|
|
|
 |
R.Khan,
H.O.Chang,
K.Kaluarachchi,
and
D.P.Giedroc
(1996).
Interaction of retroviral nucleocapsid proteins with transfer RNAPhe: a lead ribozyme and 1H NMR study.
|
| |
Nucleic Acids Res, 24,
3568-3575.
|
 |
|
|
|
|
 |
Y.X.Feng,
T.D.Copeland,
L.E.Henderson,
R.J.Gorelick,
W.J.Bosche,
J.G.Levin,
and
A.Rein
(1996).
HIV-1 nucleocapsid protein induces "maturation" of dimeric retroviral RNA in vitro.
|
| |
Proc Natl Acad Sci U S A, 93,
7577-7581.
|
 |
|
|
|
|
 |
J.Clever,
C.Sassetti,
and
T.G.Parslow
(1995).
RNA secondary structure and binding sites for gag gene products in the 5' packaging signal of human immunodeficiency virus type 1.
|
| |
J Virol, 69,
2101-2109.
|
 |
|
|
|
|
 |
N.Sheng,
and
S.Erickson-Viitanen
(1994).
Cleavage of p15 protein in vitro by human immunodeficiency virus type 1 protease is RNA dependent.
|
| |
J Virol, 68,
6207-6214.
|
 |
|
|
|
|
 |
R.J.Gorelick,
D.J.Chabot,
A.Rein,
L.E.Henderson,
and
L.O.Arthur
(1993).
The two zinc fingers in the human immunodeficiency virus type 1 nucleocapsid protein are not functionally equivalent.
|
| |
J Virol, 67,
4027-4036.
|
 |
|
|
|
|
 |
T.Dorfman,
J.Luban,
S.P.Goff,
W.A.Haseltine,
and
H.G.Göttlinger
(1993).
Mapping of functionally important residues of a cysteine-histidine box in the human immunodeficiency virus type 1 nucleocapsid protein.
|
| |
J Virol, 67,
6159-6169.
|
 |
|
|
|
|
 |
W.G.Rice,
C.A.Schaeffer,
L.Graham,
M.Bu,
J.S.McDougal,
S.L.Orloff,
F.Villinger,
M.Young,
S.Oroszlan,
and
M.R.Fesen
(1993).
The site of antiviral action of 3-nitrosobenzamide on the infectivity process of human immunodeficiency virus in human lymphocytes.
|
| |
Proc Natl Acad Sci U S A, 90,
9721-9724.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
|